Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedApr 27, 2024
DataAggregated Company Financials
Companies31
  • 7D5.1%
  • 3M-5.6%
  • 1Y-24.4%
  • YTDn/a

Last week, the Biotech industry hasn't moved much but PeptiDream is up 5.1% in that time. As for the longer term, the industry has declined 25% in the last year. As for the next few years, earnings are expected to grow by 31% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Apr 2024JP¥753.1bJP¥198.9b-JP¥14,917,877,000.0042.4x-50.5x3.8x
Mon, 25 Mar 2024JP¥773.8bJP¥194.2b-JP¥15,457,633,000.0060.7x-50.1x4x
Wed, 21 Feb 2024JP¥834.1bJP¥196.2b-JP¥18,777,765,000.0068.9x-44.4x4.3x
Fri, 19 Jan 2024JP¥776.5bJP¥222.3b-JP¥12,605,455,000.0017.1x-61.6x3.5x
Sun, 17 Dec 2023JP¥762.6bJP¥224.2b-JP¥12,970,409,000.0016.9x-58.8x3.4x
Tue, 14 Nov 2023JP¥735.1bJP¥220.9b-JP¥8,932,487,000.0016.4x-82.3x3.3x
Thu, 12 Oct 2023JP¥803.9bJP¥223.0b-JP¥14,518,735,000.0023.3x-55.4x3.6x
Sat, 09 Sep 2023JP¥893.3bJP¥225.4b-JP¥19,581,085,000.0045.7x-45.6x4x
Mon, 07 Aug 2023JP¥894.6bJP¥223.7b-JP¥20,858,086,000.0049.8x-42.9x4x
Wed, 05 Jul 2023JP¥973.5bJP¥223.0b-JP¥19,224,671,000.0059.7x-50.6x4.4x
Fri, 02 Jun 2023JP¥947.7bJP¥218.4b-JP¥25,404,669,000.0036.7x-37.3x4.3x
Sun, 30 Apr 2023JP¥902.6bJP¥218.2b-JP¥20,062,522,000.0020.9x-45x4.1x
Tue, 28 Mar 2023JP¥918.9bJP¥218.3b-JP¥21,583,164,000.0020.6x-42.6x4.2x
Thu, 23 Feb 2023JP¥938.2bJP¥216.2b-JP¥18,991,580,000.0020.9x-49.4x4.3x
Sat, 21 Jan 2023JP¥915.2bJP¥186.8b-JP¥24,722,604,000.0039x-37x4.9x
Mon, 19 Dec 2022JP¥906.0bJP¥186.8b-JP¥24,723,433,000.0043.6x-36.6x4.8x
Wed, 16 Nov 2022JP¥938.0bJP¥180.2b-JP¥24,569,725,000.0052.9x-38.2x5.2x
Fri, 14 Oct 2022JP¥838.8bJP¥176.5b-JP¥24,974,270,000.0041.6x-33.6x4.8x
Sun, 11 Sep 2022JP¥937.9bJP¥176.4b-JP¥24,682,270,000.0051x-38x5.3x
Tue, 09 Aug 2022JP¥963.6bJP¥170.5b-JP¥18,207,878,000.0020.7x-52.9x5.7x
Thu, 07 Jul 2022JP¥885.0bJP¥171.3b-JP¥16,112,943,000.0020x-54.9x5.2x
Sat, 04 Jun 2022JP¥877.5bJP¥169.3b-JP¥13,461,721,000.0011.2x-65.2x5.2x
Mon, 02 May 2022JP¥1.0tJP¥163.9b-JP¥13,144,295,000.0013.9x-76.6x6.1x
Wed, 30 Mar 2022JP¥1.1tJP¥164.2b-JP¥13,044,654,000.0015.1x-82.4x6.5x
Fri, 25 Feb 2022JP¥994.9bJP¥159.9b-JP¥9,023,798,000.0015.3x-110.2x6.2x
Sun, 23 Jan 2022JP¥1.1tJP¥163.5b-JP¥5,447,358,000.0016.4x-199.6x6.6x
Tue, 21 Dec 2021JP¥1.2tJP¥163.5b-JP¥5,447,524,000.0018.3x-229x7.6x
Thu, 18 Nov 2021JP¥1.3tJP¥159.0b-JP¥8,895,958,000.0019.5x-150x8.4x
Sat, 16 Oct 2021JP¥1.4tJP¥147.6b-JP¥12,269,440,000.0023.8x-116.2x9.7x
Mon, 13 Sep 2021JP¥1.7tJP¥147.9b-JP¥14,140,440,000.0025.9x-120x11.5x
Wed, 11 Aug 2021JP¥1.6tJP¥148.3b-JP¥14,096,440,000.0024.3x-116.5x11.1x
Sun, 06 Jun 2021JP¥1.8tJP¥130.4b-JP¥17,249,632,000.0037.7x-106.6x14.1x
Price to Earnings Ratio

-101.8x


Total Market Cap: JP¥1.8tTotal Earnings: -JP¥17,249,632,000.00Total Revenue: JP¥130.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -75.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Japanese Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 6.2x is higher than the industry's current PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Biotechnology industry have improved over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Japanese Biotech compare with similar industries?

JP Market2.20%
Healthcare3.28%
Biotech5.11%
Biotech5.11%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4587 PeptiDreamJP¥1.62k10.5%
+JP¥19.9b		-11.4%PE69.3x
4974 Takara BioJP¥1.02k6.2%
+JP¥7.1b		-40.7%PE77.8x
2160 GNI GroupJP¥2.51k2.6%
+JP¥3.2b		146.1%PE15.5x
4599 StemRIMJP¥448.005.4%
+JP¥1.4b		-64.2%PE153.9x
4588 Oncolys BioPharmaJP¥698.004.5%
+JP¥1.0b		12.4%PS231.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4882

JP¥344.00

Perseus Proteomics

7D

14.7%

1Y

20.7%

4893

JP¥173.00

Noile-Immune Biotech

7D

13.1%

1Y

n/a

Here's Why We're Not Too Worried About Noile-Immune Biotech's (TSE:4893) Cash Burn Situation

Apr 17
Here's Why We're Not Too Worried About Noile-Immune Biotech's (TSE:4893) Cash Burn Situation

4584

JP¥136.00

Kidswell Bio

7D

-3.5%

1Y

-43.3%

4974

JP¥1,015.00

Takara Bio

7D

6.2%

1Y

-40.7%

2160

JP¥2,510.00

GNI Group

7D

2.6%

1Y

146.1%

Is GNI Group (TSE:2160) Using Too Much Debt?

Apr 12
Is GNI Group (TSE:2160) Using Too Much Debt?

4598

JP¥778.00

Delta-Fly Pharma

7D

-2.0%

1Y

-34.5%

4564

JP¥17.00

OncoTherapy Science

7D

-10.5%

1Y

-51.4%

4599

JP¥448.00

StemRIM

7D

5.4%

1Y

-64.2%

4592

JP¥419.00

SanBio

7D

-0.9%

1Y

-33.1%

4587

JP¥1,622.00

PeptiDream

7D

10.5%

1Y

-11.4%

4978

JP¥135.00

ReproCELL

7D

-1.5%

1Y

-43.0%

4563

JP¥49.00

AnGes

7D

-2.0%

1Y

-50.0%

2929

JP¥844.00

Pharma Foods International

7D

4.5%

1Y

-51.9%

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23
We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

4884

JP¥545.00

Kringle Pharma

7D

-4.6%

1Y

-36.3%

We Think Kringle Pharma (TSE:4884) Can Afford To Drive Business Growth

Mar 02
We Think Kringle Pharma (TSE:4884) Can Afford To Drive Business Growth

4588

JP¥698.00

Oncolys BioPharma

7D

4.5%

1Y

12.4%

Health Check: How Prudently Does Oncolys BioPharma (TSE:4588) Use Debt?

Feb 29
Health Check: How Prudently Does Oncolys BioPharma (TSE:4588) Use Debt?

4576

JP¥105.00

D. Western Therapeutics Institute

7D

-1.9%

1Y

-47.8%